Nucleoside 5'-triphosphate analogs as positive and negative effectors of mammalian ribonucleotide reductase.
Ribonucleotide reductase activity is strongly regulated by nucleoside 5'-triphosphates acting as positive and negative effectors. With the use of dGTP analogs, araGTP and dITP, it was found that the structural requirements of dGTP to serve as a positive effector of ADP reductase were not the same as the requirements for dGTP to serve as a negative effector of CDP and ADP reductase activities. The dTTP analogs methylenedTTP and dideoxyTTP also gave different responses in terms of activating GDP reductase activity and inhibiting CDP and ADP reductase activities. Etheno-ATP and etheno-dATP were inactive as positive and negative effectors, respectively, of CDP reductase activity. DideoxyATP was less active than dATP as a negative effector. Formycin ATP was a very poor substitute for ATP as a positive effector of CDP reductase. These studies indicate that the effector sites are very specific in terms of binding nucleoside triphosphates as positive or negative modulators of ribonucleotide reductase activity.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology*; D003854:Deoxyribonucleotides / Q000494:pharmacology; D007700:Kinetics; D051379:Mice; D012264:Ribonucleotide Reductases / Q000378:metabolism*; D012265:Ribonucleotides / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013379:Substrate Specificity
D003854:Deoxyribonucleotides; D012265:Ribonucleotides; D012264:Ribonucleotide Reductases